Your browser doesn't support javascript.
loading
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.
Martinez, Fernando J; Criner, Gerard J; Gessner, Christian; Jandl, Margret; Scherbovsky, Fernando; Shinkai, Masaharu; Siler, Thomas M; Vogelmeier, Claus F; Voves, Robert; Wedzicha, Jadwiga A; Bartels, Christian; Bottoli, Ivan; Byiers, Stuart; Cardenas, Pamela; Eckert, Joerg H; Gutzwiller, Florian S; Knorr, Barbara; Kothari, Mahavir; Parlikar, Rutvick; Tanase, Ana-Maria; Franssen, Frits M E.
Afiliação
  • Martinez FJ; Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York.
  • Criner GJ; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.
  • Gessner C; Institute for Clinical Immunology, University of Leipzig, Leipzig, Germany.
  • Jandl M; Hamburger Institut für Therapieforschung GmbH, Hamburg, Germany.
  • Scherbovsky F; Fundación Scherbovsky, Mendoza, Argentina.
  • Shinkai M; Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Tokyo, Japan.
  • Siler TM; Midwest Chest Consultants, PC, St. Charles, Missouri.
  • Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, University of Marburg, German Center for Lung Research, Marburg, Germany.
  • Voves R; Private Practice, Bismarckstraße, Feldbach, Austria.
  • Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Bartels C; Novartis Pharma AG, Basel, Switzerland.
  • Bottoli I; Novartis Pharma AG, Basel, Switzerland.
  • Byiers S; Novartis Pharma AG, Basel, Switzerland.
  • Cardenas P; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Eckert JH; Novartis Pharma AG, Basel, Switzerland.
  • Gutzwiller FS; Novartis Pharma AG, Basel, Switzerland.
  • Knorr B; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Kothari M; Novartis Healthcare Pvt. Ltd., Hyderabad, India.
  • Parlikar R; Novartis Healthcare Pvt. Ltd., Hyderabad, India.
  • Tanase AM; Novartis Pharma AG, Basel, Switzerland.
  • Franssen FME; Department of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Am J Respir Crit Care Med ; 208(4): 417-427, 2023 08 15.
Article em En | MEDLINE | ID: mdl-37411039
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bronquite Crônica / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bronquite Crônica / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2023 Tipo de documento: Article